New Developments Reveal a Molecule With a Promising Function in Terms of Cancer Treatment, Research Institute at Strasbourg School of Biotechnology Study
10/31/2012 7:36:47 AM
Researchers from Inserm and CNRS from the Institute for genetics and molecular and cellular biology (IGBMC) and from the Research Institute at the Strasbourg school of biotechnology (Irebs) have focussed their efforts on PARG, currently thought to be a promising new therapeutic target in the treatment of cancer. Their work has revealed the role of this molecule in regulating gene expression. The results were published on 25 October 2012 in the on-line Molecular Cell review.
comments powered by